Ozagrel Trometamol

氨丁三醇奥扎格雷

Report date: 2022/02/22 14:45:37

Base Information

Drug NameOzagrel Trometamol
Drug Alias Name奥扎格雷氨丁三醇盐
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThromboxane A2 synthase inhibitors
TargetsThromboxane A2 synthase
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesWuhan Hengxinyuan Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWuhan Hengxinyuan Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsThrombosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A